PCA3 is a noncoding RNA biomarker that can be collected and detected in urine, and it has been found to be greatly overexpressed in 95% of PCa tissue when compared to normal prostate tissue from the same patient. The gene discussed is PCA3; the disease is posterior cortical atrophy.